Consortium of X-Chem, Harvard T.H. Chan School of Public Health and other leading academic institutions wins research award from the Department of Defense

X-Chem, Inc.
Nov. 3, 2017, 5:53 a.m.

– Funding of $9.9 million by Department of Defense, Congressionally Directed Medical Research Programs to discover new treatments for TB
– Collaboration leverages unique genetic expertise and X-Chem’s proprietary DEXTM Platform to identify novel drugs against the deadly infectious disease

To read the full press release, click here.


Source: X-Chem, Inc.